4-(N-Maleimido)benzophenone - CAS 92944-71-3
Catalog: |
BB040723 |
Product Name: |
4-(N-Maleimido)benzophenone |
CAS: |
92944-71-3 |
Synonyms: |
1-(4-benzoylphenyl)pyrrole-2,5-dione |
IUPAC Name: | 1-(4-benzoylphenyl)pyrrole-2,5-dione |
Description: | Maleimide-containing benzophenone as photoinitiator. |
Molecular Weight: | 277.27 |
Molecular Formula: | C17H11NO3 |
Canonical SMILES: | C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)N3C(=O)C=CC3=O |
InChI: | InChI=1S/C17H11NO3/c19-15-10-11-16(20)18(15)14-8-6-13(7-9-14)17(21)12-4-2-1-3-5-12/h1-11H |
InChI Key: | OZIZEXQRIOURIJ-UHFFFAOYSA-N |
Boiling Point: | 472.9 °C at 760 mmHg |
Density: | 1.33 g/cm3 |
Appearance: | Solid |
LogP: | 2.41200 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2021299266-A1 | Compositions and methods of treating muscle dystrophy | 20200327 |
US-2021301290-A1 | Compositions and methods of treating facioscapulohumeral muscular dystrophy | 20200319 |
KR-20210117209-A | Anti-cancer Drug Based on Nucleic Acid | 20200318 |
WO-2021187902-A1 | Nucleic acid-based anticancer agent | 20200318 |
WO-2021146218-A1 | Anti-gal3 antibodies and methods of use | 20200113 |
PMID | Publication Date | Title | Journal |
22304380 | 20120221 | Using a low denaturant model to explore the conformational features of translocation-active SecA | Biochemistry |
22690349 | 20120101 | Structure and pathology of tau protein in Alzheimer disease | International journal of Alzheimer's disease |
21888553 | 20110701 | Crosslinking of (cytosine-5)-DNA methyltransferase SsoII and its complexes with specific DNA duplexes provides an insight into their structures | Nucleosides, nucleotides & nucleic acids |
21628898 | 20110101 | Cross-link formation between mutant galectins of Caenorhabditis elegans with a substituted cysteine residue and asialofetuin via a photoactivatable bifunctional reagent | Biological & pharmaceutical bulletin |
20930491 | 20101001 | Side chain orientation of the amino acid substituted by a cysteine residue is important for successful crosslinking of galectin to its glycoprotein ligand using a photoactivatable sulfhydryl reagent | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan |
Complexity: | 450 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 277.07389321 |
Formal Charge: | 0 |
Heavy Atom Count: | 21 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 277.07389321 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 54.4 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS